Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

RNA splicing therapeutics for beta cell dysfunction and diabetes

Cel

Diabetes is a progressive metabolic disorder driven by beta cell dysfunction and failure, ultimately leading to chronic hyperglycemia and severe clinical complications. Current anti-diabetic treatments, including insulin secretagogues and incretin mimetics, primarily aim to control blood glucose levels without addressing the underlying molecular defects that drive beta cell decline, which in some cases even accelerate their exhaustion. Alternative splicing has recently emerged as a fundamental regulator of beta cell identity, glucose sensing, and insulin secretion, offering a novel therapeutic entry point. Our ERC-funded research uncovered a conserved program of islet-enriched microexons (IsletMICs), 3-51 nt exons controlling key genes in stimulus-secretion coupling. We have shown that splice-switching antisense oligonucleotides (SSOs) targeting specific IsletMICs can potentiate glucose-stimulated insulin secretion in human beta cells. This ERC PoC will advance a first-in-class RNA therapeutic for diabetes and other beta-cell related diseases through three integrated work packages: (1) develop a high-throughput screening pipeline to systematically test the effects of hundreds of SSOs on beta cell function; (2) targeted delivery using SSO-peptide conjugation and validation in primary human islets and hepatocytes for efficacy and toxicity in vitro studies; and (3) preclinical testing in a diabetic mouse model for biodistribution, safety, and glycemic control under a clinically relevant setting of beta cell dysfunction. By project completion, we will deliver a high-throughput platform for target discovery with subsequent decisive preclinical evidence, an optimised lead for selective beta cell delivery, and a roadmap for advancing into regulatory studies and engagement with pharmaceutical partners.

Dziedzina nauki (EuroSciVoc)

Program(-y)

Temat(-y)

System finansowania

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Wyświetl wszystkie projekty finansowane w ramach tego programu finansowania

Zaproszenie do składania wniosków

(odnośnik otworzy się w nowym oknie) ERC-2025-POC

Wyświetl wszystkie projekty finansowane w ramach tego zaproszenia

Instytucja przyjmująca

UNIVERSIDAD POMPEU FABRA
Wkład UE netto
€ 150 000,00
Koszt całkowity
Brak danych

Beneficjenci (1)